La Administración Nacional de Medicamentos (ANMAT) de Argentina dio el visto bueno, bajo la modalidad de «registro de emergencia«, al uso de la vacuna contra el coronavirus desarrollada por la Universidad de Oxford y el gigante farmacéutico británico-sueco AstraZeneca.
El producto, para el cual el país sudamericano tiene un acuerdo de fabricación, fue inscrito en el «Registro de Especialidades Medicinales (REM)» por el plazo de un año, indicó el organismo en su resolución.
ADVERTISEMENT
245729 397339I wanted to say Appreciate providing these details, youre performing a terrific job with the web site… 674320
Hello! I’ve been reading your site for a while now and finally got the courage
to go ahead and give you a shout out from Huffman Texas!
Just wanted to say keep up the great job!
Patients who have AIDS and P viagra premature ejaculation
712461 984606An intriguing discussion is worth comment. I do believe that you really should write read more about this topic, it will not be considered a taboo subject but generally everybody is too few to communicate in on such topics. To yet another. Cheers 683047
907644 681617Although youre any with the lucky enough choices, it comes evidently, whilst capture the fancy with the particular coveted by ly folks other helpful you you meet might possibly properly have hard times this particular dilemma. pre owned awnings 943625